C2 GROUP, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Therapeutic discovery tax credits (H.R. 3962, S. 1796); H.R. 3590; counter measure and orphan drug exemption from pharmaceutical excise tax; Implementation of Section 48D if the IRC, Implementation of Therapeutic Discovery Research Tax Credit.;H.R.5297, Small Business Jobs and Credit Act 2010; H.R.4213/S.3793 Tax Extenders Act of 2009; Small business capital gains incentives for biotech companies;AMT credits in lieu of bonus depreciation for biotech companies
| Lobbyist | Covered position, as disclosed |
|---|---|
| G HUNTER BATES | — |
| JOHN CLINE | — |
| THOMAS CRAWFORD | — |
| LESLEY ELLIOTT | — |
| MICHAEL HANSON | — |
| ROLAND NELSON LITTERST | — |
| JEFFERIES MURRAY | — |
| DAVID PATRICK ROBERTSON | Leg. Aide & Leg. Correspondent, Sen. Rockefeller |
Copyright/Patent/Trademark CPT
Reform Patent laws to encourage innovation (S. 515, S. 610).
| Lobbyist | Covered position, as disclosed |
|---|---|
| G HUNTER BATES | — |
| JOHN CLINE | — |
| THOMAS CRAWFORD | — |
| LESLEY ELLIOTT | — |
| MICHAEL HANSON | — |
| ROLAND NELSON LITTERST | — |
| JEFFERIES MURRAY | — |
| DAVID PATRICK ROBERTSON | Leg. Aide & Leg. Correspondent, Sen. Rockefeller |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.